Papers
15
Total Citations
127
H-Index
7
About
Francesco Di Bello is a leading researcher in uro-oncological surgery, with a primary focus on robotic-assisted procedures for prostate, bladder, and kidney cancers. His work critically evaluates the adoption, outcomes, and cost-effectiveness of robotic platforms compared to traditional open surgery. Di Bello’s major contributions include landmark studies using large national databases, such as the National Inpatient Sample, to demonstrate that robot-assisted radical cystectomy and nephroureterectomy are associated with fewer adverse in-hospital outcomes than their open counterparts. His 2025 paper “A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery” has already garnered 25 citations, reflecting its timely impact. He has also advanced personalized prostate cancer care by identifying predictors of histopathological features and continence recovery after robot-assisted radical prostatectomy, including the role of prostatic shape and gland asymmetry. Di Bello’s systematic review on prostate cancer management in patients with prior colorectal cancer highlights his commitment to addressing complex clinical scenarios. With multiple high-impact publications in 2025 alone, his research is shaping evidence-based guidelines for minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2In-Hospital Outcomes after Robotic <i>Vs</i> Open Radical Nephroureterectomy16 citations · 2025
- 3
- 4
- 5
- 6Costs of robot-assisted vs. open approaches for 5 major cancers8 citations · 2025
- 7
- 8
- 9
- 10